Lotus Other Current Assets vs Other Current Liab Analysis

LOTUSEYE

59.05 2.03 3.32%

Lotus Eye financial indicator trend analysis is infinitely more than just investigating Lotus Eye Hospital recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lotus Eye Hospital is a good investment. Please check the relationship between Lotus Eye Other Current Assets and its Other Current Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Eye Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Other Current Assets vs Other Current Liab

Other Current Assets vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lotus Eye Hospital Other Current Assets account and Other Current Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Lotus Eye's Other Current Assets and Other Current Liab is 0.9. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Lotus Eye Hospital, assuming nothing else is changed. The correlation between historical values of Lotus Eye's Other Current Assets and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Lotus Eye Hospital are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Other Current Assets i.e., Lotus Eye's Other Current Assets and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Other Current Liab

Most indicators from Lotus Eye's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lotus Eye Hospital current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lotus Eye Hospital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Tax Provision is likely to rise to about 13.3 M in 2025, whereas Selling General Administrative is likely to drop slightly above 12.7 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	976K	2.0M	1.8M	1.5M
Depreciation And Amortization	29.8M	37.3M	42.9M	33.6M

Interest Expense Depreciation And Amortization

Lotus Eye fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Accounts Payable	Net Receivables	Short Term Debt	Retained Earnings	Intangible Assets	Long Term Debt
Common Stock Shares Outstanding		0.13	0.43	-0.84	-0.74	0.26	-0.42	-0.15	0.25	0.36	0.12	0.36	0.41	0.48	-0.88	0.04	-0.66	-0.15	-0.3	0.02	-0.27	-0.64	0.19	0.31	0.0	-0.4
Total Assets	0.13		0.6	0.19	0.17	0.98	-0.03	0.0	0.18	0.8	-0.23	0.49	0.4	0.44	0.29	-0.4	0.22	0.79	-0.55	-0.18	0.05	0.01	0.8	0.87	-0.52	-0.39
Short Long Term Debt Total	0.43	0.6		-0.23	-0.37	0.65	-0.32	-0.1	0.34	0.48	0.06	0.49	0.74	0.23	-0.18	-0.34	-0.24	0.48	-0.59	-0.1	-0.23	-0.12	0.62	0.75	-0.25	-0.38
Other Current Liab	-0.84	0.19	-0.23		0.85	0.03	0.42	0.25	-0.29	0.04	-0.24	-0.3	-0.2	-0.11	0.9	-0.35	0.8	0.25	0.07	-0.17	0.21	0.47	0.01	-0.06	-0.21	0.38
Total Current Liabilities	-0.74	0.17	-0.37	0.85		-0.01	0.49	0.32	-0.38	0.04	-0.27	-0.19	-0.15	-0.12	0.74	-0.19	0.98	0.23	0.25	0.15	0.25	0.34	0.05	-0.15	-0.18	0.15
Total Stockholder Equity	0.26	0.98	0.65	0.03	-0.01		-0.07	-0.07	0.26	0.78	-0.18	0.54	0.4	0.47	0.17	-0.36	0.03	0.78	-0.55	-0.22	0.03	-0.04	0.79	0.9	-0.51	-0.42
Property Plant And Equipment Net	-0.42	-0.03	-0.32	0.42	0.49	-0.07		0.4	-0.42	0.02	0.03	-0.4	-0.14	0.26	0.4	0.04	0.49	-0.06	0.64	-0.37	0.72	0.3	-0.15	-0.3	-0.41	0.44
Net Debt	-0.15	0.0	-0.1	0.25	0.32	-0.07	0.4		-0.97	0.37	0.42	-0.7	-0.24	0.26	0.12	0.21	0.26	-0.37	-0.06	-0.2	0.51	0.42	0.06	-0.1	-0.23	0.25
Cash	0.25	0.18	0.34	-0.29	-0.38	0.26	-0.42	-0.97		-0.2	-0.39	0.79	0.42	-0.17	-0.14	-0.29	-0.29	0.49	-0.07	0.15	-0.51	-0.42	0.1	0.28	0.14	-0.33
Non Current Assets Total	0.36	0.8	0.48	0.04	0.04	0.78	0.02	0.37	-0.2		-0.15	0.06	0.35	0.75	0.04	-0.13	0.07	0.27	-0.63	-0.36	0.22	-0.16	0.66	0.67	-0.49	-0.18
Non Currrent Assets Other	0.12	-0.23	0.06	-0.24	-0.27	-0.18	0.03	0.42	-0.39	-0.15		-0.34	-0.22	-0.18	-0.3	-0.05	-0.31	-0.22	0.07	0.04	0.22	0.59	-0.03	-0.14	0.0	0.26
Cash And Short Term Investments	0.36	0.49	0.49	-0.3	-0.19	0.54	-0.4	-0.7	0.79	0.06	-0.34		0.53	-0.06	-0.19	-0.31	-0.08	0.72	-0.14	0.39	-0.53	-0.41	0.36	0.54	0.03	-0.74
Non Current Liabilities Total	0.41	0.4	0.74	-0.2	-0.15	0.4	-0.14	-0.24	0.42	0.35	-0.22	0.53		0.19	-0.25	-0.22	0.07	0.29	-0.21	0.19	-0.2	-0.41	0.32	0.34	-0.05	-0.36
Inventory	0.48	0.44	0.23	-0.11	-0.12	0.47	0.26	0.26	-0.17	0.75	-0.18	-0.06	0.19		-0.17	-0.03	-0.1	-0.04	-0.27	-0.64	0.27	-0.46	0.37	0.43	-0.54	0.11
Other Current Assets	-0.88	0.29	-0.18	0.9	0.74	0.17	0.4	0.12	-0.14	0.04	-0.3	-0.19	-0.25	-0.17		-0.25	0.68	0.43	0.02	-0.25	0.31	0.54	0.17	0.07	-0.31	0.32
Other Stockholder Equity	0.04	-0.4	-0.34	-0.35	-0.19	-0.36	0.04	0.21	-0.29	-0.13	-0.05	-0.31	-0.22	-0.03	-0.25		-0.23	-0.5	0.18	0.15	0.17	-0.11	-0.42	-0.37	0.49	-0.06
Total Liab	-0.66	0.22	-0.24	0.8	0.98	0.03	0.49	0.26	-0.29	0.07	-0.31	-0.08	0.07	-0.1	0.68	-0.23		0.27	0.25	0.2	0.21	0.25	0.08	-0.12	-0.17	0.08
Total Current Assets	-0.15	0.79	0.48	0.25	0.23	0.78	-0.06	-0.37	0.49	0.27	-0.22	0.72	0.29	-0.04	0.43	-0.5	0.27		-0.24	0.07	-0.14	0.17	0.61	0.7	-0.34	-0.44
Common Stock	-0.3	-0.55	-0.59	0.07	0.25	-0.55	0.64	-0.06	-0.07	-0.63	0.07	-0.14	-0.21	-0.27	0.02	0.18	0.25	-0.24		0.19	0.24	0.1	-0.68	-0.73	0.21	0.21
Current Deferred Revenue	0.02	-0.18	-0.1	-0.17	0.15	-0.22	-0.37	-0.2	0.15	-0.36	0.04	0.39	0.19	-0.64	-0.25	0.15	0.2	0.07	0.19		-0.43	-0.02	-0.23	-0.24	0.64	-0.59
Accounts Payable	-0.27	0.05	-0.23	0.21	0.25	0.03	0.72	0.51	-0.51	0.22	0.22	-0.53	-0.2	0.27	0.31	0.17	0.21	-0.14	0.24	-0.43		0.39	0.13	-0.13	-0.43	0.48
Net Receivables	-0.64	0.01	-0.12	0.47	0.34	-0.04	0.3	0.42	-0.42	-0.16	0.59	-0.41	-0.41	-0.46	0.54	-0.11	0.25	0.17	0.1	-0.02	0.39		0.04	-0.1	-0.11	0.33
Short Term Debt	0.19	0.8	0.62	0.01	0.05	0.79	-0.15	0.06	0.1	0.66	-0.03	0.36	0.32	0.37	0.17	-0.42	0.08	0.61	-0.68	-0.23	0.13	0.04		0.86	-0.69	-0.25
Retained Earnings	0.31	0.87	0.75	-0.06	-0.15	0.9	-0.3	-0.1	0.28	0.67	-0.14	0.54	0.34	0.43	0.07	-0.37	-0.12	0.7	-0.73	-0.24	-0.13	-0.1	0.86		-0.48	-0.45
Intangible Assets	0.0	-0.52	-0.25	-0.21	-0.18	-0.51	-0.41	-0.23	0.14	-0.49	0.0	0.03	-0.05	-0.54	-0.31	0.49	-0.17	-0.34	0.21	0.64	-0.43	-0.11	-0.69	-0.48		-0.24
Long Term Debt	-0.4	-0.39	-0.38	0.38	0.15	-0.42	0.44	0.25	-0.33	-0.18	0.26	-0.74	-0.36	0.11	0.32	-0.06	0.08	-0.44	0.21	-0.59	0.48	0.33	-0.25	-0.45	-0.24

Click cells to compare fundamentals

Lotus Eye Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Lotus Stock Analysis

When running Lotus Eye's price analysis, check to measure Lotus Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Eye is operating at the current time. Most of Lotus Eye's value examination focuses on studying past and present price action to predict the probability of Lotus Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Eye's price. Additionally, you may evaluate how the addition of Lotus Eye to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lotus Other Current Assets vs Other Current Liab Analysis

Other Current Assets vs Other Current Liab

Other Current Assets vs Other Current Liab Correlation Analysis

Correlation Coefficient

Other Current Assets

Other Current Liab

Lotus Eye fundamental ratios Correlations

Lotus Eye Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Lotus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Current Liabilities
Other Current Assets	+ 0.9	Other Current Liab
Retained Earnings	+ 0.9	Total Stockholder Equity
Retained Earnings	+ 0.87	Total Assets
Retained Earnings	+ 0.86	Short Term Debt

Cash	- 0.97	Net Debt
Other Current Assets	- 0.88	Common Stock Shares Outstanding
Other Current Liab	- 0.84	Common Stock Shares Outstanding
Long Term Debt	- 0.74	Cash And Short Term Investments
Total Current Liabilities	- 0.74	Common Stock Shares Outstanding
Retained Earnings	- 0.73	Common Stock